ULTRAGENYX PHARMACEUTICAL INC.
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2021 | $599.8M | $1.52B | $307.6M |
| FY2022 | $1.19B | $1.55B | $132.9M |
| FY2023 | $1.22B | $1.49B | $214.0M |
| FY2024 | $1.24B | $1.50B | $174.0M |
| FY2025 | $1.61B | $1.53B | $421.0M |